Background: Ardhavabhedaka, a type of Shiro Roga described in Ayurveda, closely resembles migraine in modern medicine. Migraine is a chronic neurological disorder characterized by recurrent unilateral headaches associated with nausea, photophobia, and phonophobia. A subset of patients remains refractory to conventional pharmacological treatment, necessitating alternative therapeutic approaches. Objective: To evaluate the therapeutic efficacy of Aja Dugdh Nasya in a drug-resistant case of Ardhavabhedaka (migraine) using clinical outcome measures. Methods: A single-case clinical study was conducted on a 45-year-old female patient presenting with chronic migraine unresponsive to conventional therapy. The patient was treated with Aja Dugdh Nasya for 21 days. Assessment was performed using a standardized grading system for headache severity, frequency, duration, and associated symptoms. Results: Significant improvement was observed in headache intensity, frequency, duration, and associated symptoms such as nausea, vertigo, and photophobia. No adverse effects were reported. Conclusion: Aja Dugdh Nasya appears to be a safe and effective therapeutic modality for managing drug-resistant migraine. This study supports the potential of integrative Ayurvedic approaches in chronic neurological disorders.
1Dr. Jinesh Kumar Jain, 2Dr. O. P. Dwivedi, 3*Dr. Neeraj Kumar Khare (Fri,) studied this question.